Home>Equipment list>Security check>Drug, gas, liquid, biochemical detection equipment>Multiple drug joint testing kits (morphine/methamphetamine/ketamine)
细节展示放大镜特效

Multiple drug joint testing kits (morphine/methamphetamine/ketamine)

  • No:Multi-drug Joint Detection Kit
  • Quantity:

      Recommend

    1, drip hole type / insert type, colloid gold method, 1 person independent packaging, 25 people / box, 1000 people / box

    2, this product uses colloidal gold and immunotomography technology qualitative detection of human urine samples with a critical concentration of 300 ng/ml of morphine, 1000 ng/ml of methamphetamine and 1000 ng/ml of ketamine, suitable for morphine, methamphetamine and ketamine initial screening test; Easy to operate;

    3, the original packaging should be stored in 2 degrees C - 30 degrees C, cool to avoid the light dry place, valid for 24 months;

    4, the State Drug Administration registration certificate number: National Equipment Note 20183401602. And access to the quality management system certification: ISO9001:2008, ISO13485:2003;

    5, invention patents:

    Patented in 2009 for "Methamphetamine monoantigen kit that does not cross-react with ephedrine and pseudoephedrine"

    Patented in 2006 for monoclonal antibodies and immunoassays for ketamine testing

    6, the certificate:

    In 2008, he won the third prize of the Science and Technology Award of the Ministry of Public Security ," Research on the establishment of "Ice" methamphetamine monoimmune testing method

    In 2007, he won the third prize of the Science and Technology Award of the Ministry of Public Security, "Research and development of the new drug ketamine gold standard monoclonal antibody immunoassays"

    2007 won the first prize of the Shanghai Public Security Bureau Science and Technology Project Award "Research and development of the new drug ketamine gold standard monoclonal antibody immunoassays"

    7, shortlisted the Directory of the Ministry of Public Security of the People's Republic of China, and entered the Notice on the Publication of the Results of drug Testing Kit Inspection Evaluation